Syntal Capital Partners’s Halozyme HALO Stock Holding History

Syntal Capital Partners’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-35,538	Closed	-$1.52K	–	133
2020 Q4	$1.52K	Buy	+35,538	New	+$1.28M	0.19%	53

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Syntal Capital Partners's HALO Position: Q1 2021 in Review

Syntal Capital Partners sold out of Halozyme (HALO) in Q1 2021, closing a stake of 35,538 shares — an estimated $1.52K sold.

Syntal Capital Partners first reported a position in HALO in Q4 2020 and held it in 1 quarter. The position peaked at $1.52K in Q4 2020. 336 funds tracked by Wall St. Rank hold HALO as of Q1 2021.

Syntal Capital Partners reported no remaining Halozyme position as of Q1 2021 after selling out during the quarter.
Syntal Capital Partners sold 35,538 Halozyme shares in Q1 2021, an estimated $1.52K.
Syntal Capital Partners first reported a position in Halozyme in Q4 2020 and held it in 1 quarter.
Syntal Capital Partners's Halozyme position peaked at $1.52K in Q4 2020.
336 funds tracked by Wall St. Rank held Halozyme as of Q1 2021.

Based on Syntal Capital Partners's 13F filing for Q1 2021, filed 17 May 2021.